Sie sind auf Seite 1von 1

10678

Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices

Drug

Schedule

Oxycodone (9143) Hydromorphone (9150) Benzoylecgonine (9180) Ethylmorphine (9190) Meperidine (9230) Methadone (9250) Dextropropoxyphene, bulk (non- dosage forms) (9273). Morphine (9300) Thebaine (9333) Levo-alphacetylmethadol (9648) Oxymorphone (9652)

II

II

II

II

II

II

II

II

II

II

II

The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. sections 823(a) and 952(a) and determined that the registration of Cerilliant Corporation to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cerilliant Corporation to ensure that the companys registration is consistent with the public interest. The investigation has included inspection and testing of the companys physical security systems, verification of the companys compliance with state and local laws, and a review of the companys background and history. Therefore, pursuant to 21 U.S.C. sections 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed.

Dated: February 22, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 054234 Filed 3305; 8:45 am]

BILLING CODE 441009P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By notice dated September 28, 2004, and published in the Federal Register on October 13, 2004, (69 FR 60898), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes

of controlled substances listed in Schedules I and II:

Drug

Schedule

N-Ethylamphetamine (1475)

I

4-Methoxyamphetamine (7411)

I

2,5-Dimethoxyamphetamine

I

(7396).

Difenoxin (9168)

I

Amphetamine (1100)

II

Methamphetamine (1105)

II

Methylphenidate (1724)

II

Pentobarbital (2270) Secobarbital (2315) Codeine (9050) Oxycodone (9143) Diphenoxylate (9170) Hydrocodone (9193) Meperidine (9230) Dextropropoxyphene, bulk (9273) Morphine (9300) Thebaine (9333) Alfentanil (9737) Sufentanil (9740) Fentanyl (9801)

II

II

II

II

II

II

II

II

II

II

II

II

II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals, Inc. to ensure that the companys registration is consistent with the public interest. The investigation has included inspection and testing of the companys physical security systems, verification of the companys compliance with state and local laws, and a review of the companys background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 23, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 054230 Filed 3305; 8:45 am]

BILLING CODE 441009P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated November 8, 2004, and published in the Federal Register on November 22, 2004, (69 FR 67962

67963), ISP, Freetown Fine Chemicals, Inc., 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement

Administration (DEA) for registration as

a bulk manufacturer of the basic classes

of controlled substances listed in Schedules I and II:

Drug

Schedule

2,5-Dimethoxyamphetamine

(7396).

Amphetamine (1100)

Phenylacetone (8501)

I

II

II

The company plans to manufacture

phenylacetone to be used in the

manufacture of the amphetamine. The

bulk 2, 5-dimethoxyamphetamine will

be used for conversion into non-

controlled substances.

No comments or objections have been

received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of ISP, Freetown Fine Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated ISP, Freetown Fine Chemicals, Inc. to ensure that the companys registration is consistent with the public interest. The investigation has included inspection and testing of the companys physical security systems, verification of the companys compliance with state and local laws, and a review of the companys background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 22, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 054197 Filed 3305; 8:45 am]

BILLING CODE 441009P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated November 1, 2004, and published in the Federal Register on November 10, 2004, (69 FR 65229), Guilford Pharmaceuticals, Inc., 6611 Tributary Street, Baltimore, Maryland 21224, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk

VerDate jul<14>2003

19:07 Mar 03, 2005

Jkt 205001

PO 00000

Frm 00088

Fmt 4703

Sfmt 4703

E:\FR\FM\04MRN1.SGM

04MRN1